Literature DB >> 17422791

Malignant hyperthermia in dogs.

P J O'brien.   

Abstract

Entities:  

Year:  1987        PMID: 17422791      PMCID: PMC1680654     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


× No keyword cloud information.
  8 in total

1.  Red cell osmotic fragility in the Beagle dog: normal values and diagnostic application.

Authors:  D E Hall; A J Follett
Journal:  Vet Rec       Date:  1972-09-09       Impact factor: 2.695

2.  Canine stress syndrome.

Authors:  P J O'Brien; J S Rand
Journal:  J Am Vet Med Assoc       Date:  1985-03-01       Impact factor: 1.936

3.  Porcine malignant hyperthermia susceptibility: increased calcium-sequestering activity of skeletal muscle sarcoplasmic reticulum.

Authors:  P J O'Brien
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

4.  Porcine malignant hyperthermia susceptibility: hypersensitive calcium-release mechanism of skeletal muscle sarcoplasmic reticulum.

Authors:  P J O'Brien
Journal:  Can J Vet Res       Date:  1986-07       Impact factor: 1.310

5.  Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis.

Authors:  P J O'Brien; G W Forsyth; D W Olexson; H S Thatte; P B Addis
Journal:  Can J Comp Med       Date:  1984-10

6.  Porcine malignant hyperthermia susceptibility: erythrocytic osmotic fragility.

Authors:  P J O'Brien; M T Rooney; T R Reik; H S Thatte; W E Rempel; P B Addis; C F Louis
Journal:  Am J Vet Res       Date:  1985-07       Impact factor: 1.156

7.  Canine malignant hyperthermia: diagnosis of susceptibility in a breeding colony.

Authors:  P J O'brien; P H Cribb; R J White; E D Olfert; J E Steiss
Journal:  Can Vet J       Date:  1983-06       Impact factor: 1.008

8.  Exercise-induced malignant hyperthermia in an English springer spaniel.

Authors:  J S Rand; P J O'Brien
Journal:  J Am Vet Med Assoc       Date:  1987-04-15       Impact factor: 1.936

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.